1980
DOI: 10.1128/aem.40.6.1017-1022.1980
|View full text |Cite
|
Sign up to set email alerts
|

Biochemical characterization of cholesterol-reducing Eubacterium

Abstract: We characterized two isolates of cholesterol-reducing Eubacterium by conducting conventional biochemical tests and by testing various sterols and glycerolipids as potential growth factors. In media containing cholesterol and plasmenylethanolamine, the tests for nitrate reduction, indole production, and gelatin and starch hydrolyses were negative, and no acid was produced from any of 22 carbohydrates. Both isolates hydrolyzed esculin to esculetin, indicating ,B-glycosidase activity. In addition to plasmenyletha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

1988
1988
2021
2021

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 18 publications
0
17
0
Order By: Relevance
“…are able to degrade two cholesterol metabolites (coprostenol (cholest-4-en-3β-ol) and cholestenone) into coprostanol. [28,32] In contrast, Ren et al, [34] using pure culture of Eubacterium coprostanoligenes found no production of intermediary metabolites such as cholesterone and cholestenone, which could imply that the conversion of cholesterol into coprostanol occurs through route I ( Figure 1). Besides, it has also been found that Bacteroides thetaiomicrom produces a larger amount of coprostanol than Bifidobacterium sp.…”
Section: Dietary Sterols Biotransformation By Gut Microbiotamentioning
confidence: 91%
See 2 more Smart Citations
“…are able to degrade two cholesterol metabolites (coprostenol (cholest-4-en-3β-ol) and cholestenone) into coprostanol. [28,32] In contrast, Ren et al, [34] using pure culture of Eubacterium coprostanoligenes found no production of intermediary metabolites such as cholesterone and cholestenone, which could imply that the conversion of cholesterol into coprostanol occurs through route I ( Figure 1). Besides, it has also been found that Bacteroides thetaiomicrom produces a larger amount of coprostanol than Bifidobacterium sp.…”
Section: Dietary Sterols Biotransformation By Gut Microbiotamentioning
confidence: 91%
“…Sterols biotransformation by the gut microbiota has been widely studied by in vitro assays using microbiota from human, [18][19][20][21][22][23][24] rat, [25][26][27] pigeon, and chicken feces. [24] In addition, pure cultures of enteric microorganisms such as Eubacterium sp., [28][29][30][31][32][33][34] Clostridium perfringens, Bifidobacterium sp., Enterobacter aerogenes, [35] Escherichia coli, [35,36] Bacteroides sp. [37] have been used in order to study cholesterol metabolites.…”
Section: Dietary Sterols Biotransformation By Gut Microbiotamentioning
confidence: 99%
See 1 more Smart Citation
“…The changes of fecal neutral sterols, namely the disappearance of coprostanol, were observed in the feces in rats given the HSO diet (Table 4), suggesting a shift in enterobacteria, for example, a decrease in the population of bacteria such as Eubacterium having a specific enzyme that reduces cholesterol to coprostanol (27), although we did not perform bacteriological examinations.…”
Section: Table 4 Effects Of Dietary Pcbs and Highly Hydrogenated Soybmentioning
confidence: 99%
“…Later, Mott et al (1980) further characterized cholesterol-reducing bacteria, including E. ATCC 21408 and E. 403, by conducting conventional biochemical tests and by testing different sterols and glycerolipids as potential growth factors. In media containing cholesterol and plasmenylethanolamine, the tests for nitrate reduction, indole production, and gelatin and starch hydrolyses were negative, and no acid was produced from any of 22 different carbohydrates.…”
Section: Cholesterol-reducing Bacteriamentioning
confidence: 99%